Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 12/10/24 → 12/9/26 |
Funding
- Basilea Pharmaceutica International Ltd Allschwil: $25,400.00
Candida 301: An Interventional Efficacy and Safety Phase 3 Double-Blind 2-Arm Study to Investigate IV Followed by Oral Fosmanogepix Compared with IV Caspofungin Followed by Oral Fluconazole in Adult Participants with Candidemia and/or Invasive Candidiasis
- Greenberg, Richard (PI)